Go Pro
NASDAQ:NTRB

Nutriband Q2 2027 Earnings Report

Nutriband logo
$7.28 -0.08 (-1.09%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$7.43 +0.15 (+2.02%)
As of 10/2/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nutriband EPS Results

Actual EPS
-$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nutriband Revenue Results

Actual Revenue
$0.44 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nutriband Announcement Details

Quarter
Q2 2027
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Nutriband's next earnings date is estimated for Monday, December 7, 2026, based on past reporting schedules.

Conference Call Resources

Nutriband Earnings Headlines

First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
Financial Review: Evolus (NASDAQ:EOLS) vs. Nutriband (NASDAQ:NTRB)
See More Nutriband Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nutriband? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nutriband and other key companies, straight to your email.

About Nutriband

Nutriband (NASDAQ:NTRB) is a medical technology company that develops, manufactures and commercializes transdermal and topical delivery products. Its technologies are designed to deliver medications or other active ingredients through the skin using adhesive patches and related wearable formats.

The company offers product development and manufacturing services for prescription, over-the-counter, consumer health and cosmetic applications. Its portfolio includes transdermal patches and other topical delivery systems, with products intended for areas such as pain management, wellness and pharmaceutical drug delivery.

Nutriband also develops its AVERSA technology, a platform designed to help deter the abuse and misuse of transdermal medications by incorporating deterrent components into patches. The company serves pharmaceutical, healthcare and consumer-product partners and is based in Orlando, Florida.

View Nutriband Profile